APO Research
Talk to an analyst

APO RESEARCH · REPORT

Yellow Fever Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Yellow Fever Vaccines Market Outlook and Growth Opportunities 2026

29 December 2025197 pages

Choose your research edition.

Industry ResearchYellow Fever Vaccines Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Yellow Fever Vaccines Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Yellow Fever Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Yellow Fever Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Yellow Fever Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Yellow Fever Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Yellow Fever Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Yellow Fever Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Yellow Fever Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Yellow Fever Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Yellow Fever Vaccines market include Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar and Sanofi Pasteur, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Yellow Fever Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Yellow Fever Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Yellow Fever Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Yellow Fever Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Yellow Fever Vaccines Segment by Company

Bio-Manguinhos

FSUE Chumakov

Institut Pasteur de Dakar

Sanofi Pasteur

Yellow Fever Vaccines Segment by Type

Institonal Contributions

Private Purchase

Others

Yellow Fever Vaccines Segment by Application

Routine Immunization

Travelers

Other

Yellow Fever Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Yellow Fever Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Yellow Fever Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Yellow Fever Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Yellow Fever Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yellow Fever Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Yellow Fever Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yellow Fever Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Yellow Fever Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Yellow Fever Vaccines industry.

Chapter 3: Detailed analysis of Yellow Fever Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Yellow Fever Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Yellow Fever Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Yellow Fever Vaccines Industry Trends Table 2. Yellow Fever Vaccines Industry Drivers Table 3. Yellow Fever Vaccines Industry Opportunities and Challenges Table 4. Yellow Fever Vaccines Industry Restraints Table 5. Global Yellow Fever Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Yellow Fever Vaccines Revenue Share by Company (2021-2026) Table 7. Global Yellow Fever Vaccines Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Yellow Fever Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Yellow Fever Vaccines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Yellow Fever Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Yellow Fever Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Yellow Fever Vaccines Company, Product Type & Application Table 13. Global Yellow Fever Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Yellow Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Institonal Contributions Table 18. Significant Companies of Private Purchase Table 19. Significant Companies of Others Table 20. Global Yellow Fever Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Yellow Fever Vaccines Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Yellow Fever Vaccines Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Yellow Fever Vaccines Sales Volume Share by Type (2021-2026) Table 24. Global Yellow Fever Vaccines Sales Volume Share by Type (2027-2032) Table 25. Global Yellow Fever Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Yellow Fever Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Yellow Fever Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Yellow Fever Vaccines Sales Value Share by Type (2021-2026) Table 29. Global Yellow Fever Vaccines Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Routine Immunization Table 31. Significant Companies of Travelers Table 32. Significant Companies of Other Table 33. Global Yellow Fever Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Yellow Fever Vaccines Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Yellow Fever Vaccines Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Yellow Fever Vaccines Sales Volume Share by Application (2021-2026) Table 37. Global Yellow Fever Vaccines Sales Volume Share by Application (2027-2032) Table 38. Global Yellow Fever Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Yellow Fever Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Yellow Fever Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Yellow Fever Vaccines Sales Value Share by Application (2021-2026) Table 42. Global Yellow Fever Vaccines Sales Value Share by Application (2027-2032) Table 43. Global Yellow Fever Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Yellow Fever Vaccines Sales by Region (2021-2026) & (K Units) Table 45. Global Yellow Fever Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Yellow Fever Vaccines Sales by Region (2027-2032) & (K Units) Table 47. Global Yellow Fever Vaccines Sales Market Share by Region (2027-2032) Table 48. Global Yellow Fever Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Yellow Fever Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Yellow Fever Vaccines Sales Value Share by Region (2021-2026) Table 51. Global Yellow Fever Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Yellow Fever Vaccines Sales Value Share by Region (2027-2032) Table 53. Global Yellow Fever Vaccines Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Yellow Fever Vaccines Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Yellow Fever Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Yellow Fever Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Yellow Fever Vaccines Sales by Country (2021-2026) & (K Units) Table 58. Global Yellow Fever Vaccines Sales Market Share by Country (2021-2026) Table 59. Global Yellow Fever Vaccines Sales by Country (2027-2032) & (K Units) Table 60. Global Yellow Fever Vaccines Sales Market Share by Country (2027-2032) Table 61. Global Yellow Fever Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Yellow Fever Vaccines Sales Value Market Share by Country (2021-2026) Table 63. Global Yellow Fever Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Yellow Fever Vaccines Sales Value Market Share by Country (2027-2032) Table 65. Bio-Manguinhos Company Information Table 66. Bio-Manguinhos Business Overview Table 67. Bio-Manguinhos Yellow Fever Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Bio-Manguinhos Yellow Fever Vaccines Product Portfolio Table 69. Bio-Manguinhos Recent Development Table 70. FSUE Chumakov Company Information Table 71. FSUE Chumakov Business Overview Table 72. FSUE Chumakov Yellow Fever Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. FSUE Chumakov Yellow Fever Vaccines Product Portfolio Table 74. FSUE Chumakov Recent Development Table 75. Institut Pasteur de Dakar Company Information Table 76. Institut Pasteur de Dakar Business Overview Table 77. Institut Pasteur de Dakar Yellow Fever Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Institut Pasteur de Dakar Yellow Fever Vaccines Product Portfolio Table 79. Institut Pasteur de Dakar Recent Development Table 80. Sanofi Pasteur Company Information Table 81. Sanofi Pasteur Business Overview Table 82. Sanofi Pasteur Yellow Fever Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sanofi Pasteur Yellow Fever Vaccines Product Portfolio Table 84. Sanofi Pasteur Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Yellow Fever Vaccines Distributors List Table 88. Yellow Fever Vaccines Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Yellow Fever Vaccines Product Image Figure 2. Global Yellow Fever Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Yellow Fever Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Yellow Fever Vaccines Sales (2021-2032) & (K Units) Figure 5. Global Yellow Fever Vaccines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Yellow Fever Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Institonal Contributions Image Figure 10. Private Purchase Image Figure 11. Others Image Figure 12. Global Yellow Fever Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Yellow Fever Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Yellow Fever Vaccines Sales Volume Share by Type (2021-2032) Figure 15. Global Yellow Fever Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Yellow Fever Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Yellow Fever Vaccines Sales Value Share by Type (2021-2032) Figure 18. Routine Immunization Image Figure 19. Travelers Image Figure 20. Other Image Figure 21. Global Yellow Fever Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Yellow Fever Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Yellow Fever Vaccines Sales Volume Share by Application (2021-2032) Figure 24. Global Yellow Fever Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Yellow Fever Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Yellow Fever Vaccines Sales Value Share by Application (2021-2032) Figure 27. Global Yellow Fever Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Yellow Fever Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Yellow Fever Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Yellow Fever Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Yellow Fever Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. North America Yellow Fever Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Yellow Fever Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Yellow Fever Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Yellow Fever Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Yellow Fever Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Yellow Fever Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. South America Yellow Fever Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Yellow Fever Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Yellow Fever Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Yellow Fever Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Yellow Fever Vaccines Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Yellow Fever Vaccines Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Institonal Contributions
  • Private Purchase
  • Others
Applications
  • Routine Immunization
  • Travelers
  • Other
Companies covered
  • Bio-Manguinhos
  • FSUE Chumakov
  • Institut Pasteur de Dakar
  • Sanofi Pasteur

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Yellow Fever Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Yellow Fever Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Yellow Fever Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Yellow Fever Vaccines Market Dynamics
  1. 2.1 Yellow Fever Vaccines Industry Trends
  2. 2.2 Yellow Fever Vaccines Industry Drivers
  3. 2.3 Yellow Fever Vaccines Industry Opportunities and Challenges
  4. 2.4 Yellow Fever Vaccines Industry Restraints
3 Yellow Fever Vaccines Market by Company
  1. 3.1 Global Yellow Fever Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Yellow Fever Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Yellow Fever Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Yellow Fever Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Yellow Fever Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Yellow Fever Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Yellow Fever Vaccines Company Product Type and Application
  8. 3.8 Global Yellow Fever Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Yellow Fever Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Yellow Fever Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Yellow Fever Vaccines Market by Type
  1. 4.1 Yellow Fever Vaccines Type Introduction
  2. 4.1.1 Institonal Contributions
  3. 4.1.2 Private Purchase
  4. 4.1.3 Others
  5. 4.2 Global Yellow Fever Vaccines Sales Volume by Type
  6. 4.2.1 Global Yellow Fever Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Yellow Fever Vaccines Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Yellow Fever Vaccines Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Yellow Fever Vaccines Sales Value by Type
  10. 4.3.1 Global Yellow Fever Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Yellow Fever Vaccines Sales Value by Type (2021-2032)
  12. 4.3.3 Global Yellow Fever Vaccines Sales Value Share by Type (2021-2032)
5 Yellow Fever Vaccines Market by Application
  1. 5.1 Yellow Fever Vaccines Application Introduction
  2. 5.1.1 Routine Immunization
  3. 5.1.2 Travelers
  4. 5.1.3 Other
  5. 5.2 Global Yellow Fever Vaccines Sales Volume by Application
  6. 5.2.1 Global Yellow Fever Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Yellow Fever Vaccines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Yellow Fever Vaccines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Yellow Fever Vaccines Sales Value by Application
  10. 5.3.1 Global Yellow Fever Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Yellow Fever Vaccines Sales Value by Application (2021-2032)
  12. 5.3.3 Global Yellow Fever Vaccines Sales Value Share by Application (2021-2032)
6 Yellow Fever Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Yellow Fever Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Yellow Fever Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Yellow Fever Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Yellow Fever Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Yellow Fever Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Yellow Fever Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Yellow Fever Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Yellow Fever Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Yellow Fever Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Yellow Fever Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Yellow Fever Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Yellow Fever Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Yellow Fever Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Yellow Fever Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Yellow Fever Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Yellow Fever Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Yellow Fever Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Yellow Fever Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Yellow Fever Vaccines Sales Value Share by Country, 2025 VS 2032
7 Yellow Fever Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Yellow Fever Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Yellow Fever Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Yellow Fever Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Yellow Fever Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Yellow Fever Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Yellow Fever Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Yellow Fever Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Yellow Fever Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Yellow Fever Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Yellow Fever Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Yellow Fever Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bio-Manguinhos
  2. 8.1.1 Bio-Manguinhos Company Information
  3. 8.1.2 Bio-Manguinhos Business Overview
  4. 8.1.3 Bio-Manguinhos Yellow Fever Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bio-Manguinhos Yellow Fever Vaccines Product Portfolio
  6. 8.1.5 Bio-Manguinhos Recent Developments
  7. 8.2 FSUE Chumakov
  8. 8.2.1 FSUE Chumakov Company Information
  9. 8.2.2 FSUE Chumakov Business Overview
  10. 8.2.3 FSUE Chumakov Yellow Fever Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 FSUE Chumakov Yellow Fever Vaccines Product Portfolio
  12. 8.2.5 FSUE Chumakov Recent Developments
  13. 8.3 Institut Pasteur de Dakar
  14. 8.3.1 Institut Pasteur de Dakar Company Information
  15. 8.3.2 Institut Pasteur de Dakar Business Overview
  16. 8.3.3 Institut Pasteur de Dakar Yellow Fever Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Institut Pasteur de Dakar Yellow Fever Vaccines Product Portfolio
  18. 8.3.5 Institut Pasteur de Dakar Recent Developments
  19. 8.4 Sanofi Pasteur
  20. 8.4.1 Sanofi Pasteur Company Information
  21. 8.4.2 Sanofi Pasteur Business Overview
  22. 8.4.3 Sanofi Pasteur Yellow Fever Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Pasteur Yellow Fever Vaccines Product Portfolio
  24. 8.4.5 Sanofi Pasteur Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Yellow Fever Vaccines Value Chain Analysis
  2. 9.1.1 Yellow Fever Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Yellow Fever Vaccines Sales Mode & Process
  6. 9.2 Yellow Fever Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Yellow Fever Vaccines Distributors
  9. 9.2.3 Yellow Fever Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst